Abstract
We previously described a reduction of silica-induced lung fibrosis in interleukin-10-deficient mice (IL-10-/-) (Huaux and colleagues; Am. J. Respir. Cell Mol. Biol. 1998;18:51-59). In the present study, we further dissect the exact functions of IL-10 in experimental silicosis. The reduced lung fibrotic response to silica in IL-10-/- mice was accompanied by a marked recruitment of TH1 CD4+ lymphocytes. However, treatment with anti-CD4 antibodies reduced silica-induced lung fibrosis in both IL-10-/- and IL-10+/+ mice, suggesting that this T cell population actually contributes to the extension of the fibrotic lesions in a manner that is independent of IL-10. In IL-10-/- mice, silica-induced lung production of the profibrotic mediator transforming growth factor (TGF)-beta1 and the antifibrotic eicosanoid PGE2 were reduced and increased, respectively, relative to that in IL-10+/+ mice. In addition, in vitro experiments indicated that recombinant IL-10 upregulated TGF-beta1 expression in alveolar macrophages while in contrast it downregulated PGE2 production and cyclooxygenase-2 expression in both lung fibroblasts and macrophages. Thus the net profibrotic activity of IL-10 in vivo appears to be mediated by its ability to stimulate the expression of the profibrotic cytokine TGF-beta1 while suppressing the expression of cyclooxygenase-2 and thus production of the antifibrotic eicosanoid PGE2. These effects appear to be independent of the enhanced lung CD4+ T-lymphocytosis observed in IL-10-deficient mice.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antibodies / pharmacology
-
CD4-Positive T-Lymphocytes / drug effects
-
CD4-Positive T-Lymphocytes / immunology
-
Chemotaxis, Leukocyte / drug effects
-
Chemotaxis, Leukocyte / immunology
-
Cyclooxygenase 2
-
Dinoprostone / metabolism
-
Disease Models, Animal
-
Down-Regulation / drug effects
-
Down-Regulation / physiology
-
Female
-
Fibroblasts / drug effects
-
Fibroblasts / metabolism
-
Interleukin-10 / deficiency
-
Interleukin-10 / genetics*
-
Isoenzymes / drug effects
-
Isoenzymes / genetics
-
Isoenzymes / metabolism
-
Lung / drug effects
-
Lung / immunology*
-
Lung / physiopathology
-
Macrophages / drug effects
-
Macrophages / metabolism
-
Mice
-
Mice, Inbred C57BL
-
Mice, Knockout
-
Prostaglandin-Endoperoxide Synthases / drug effects
-
Prostaglandin-Endoperoxide Synthases / genetics
-
Prostaglandin-Endoperoxide Synthases / metabolism
-
Pulmonary Fibrosis / chemically induced
-
Pulmonary Fibrosis / genetics*
-
Pulmonary Fibrosis / immunology*
-
RNA, Messenger / drug effects
-
RNA, Messenger / metabolism
-
Receptors, Interleukin / drug effects
-
Receptors, Interleukin / metabolism
-
Receptors, Interleukin-10
-
Silicon Dioxide*
-
Th1 Cells / drug effects
-
Th1 Cells / immunology
-
Transforming Growth Factor beta / drug effects
-
Transforming Growth Factor beta / genetics
-
Transforming Growth Factor beta / metabolism
-
Transforming Growth Factor beta1
Substances
-
Antibodies
-
Isoenzymes
-
RNA, Messenger
-
Receptors, Interleukin
-
Receptors, Interleukin-10
-
Tgfb1 protein, mouse
-
Transforming Growth Factor beta
-
Transforming Growth Factor beta1
-
Interleukin-10
-
Silicon Dioxide
-
Cyclooxygenase 2
-
Prostaglandin-Endoperoxide Synthases
-
Dinoprostone